TherapeuticsMD
TXMD
#10160
Rank
โ‚ฌ17.29 M
Marketcap
1,49ย โ‚ฌ
Share price
8.07%
Change (1 day)
28.37%
Change (1 year)

Market capitalization of TherapeuticsMD (TXMD)

Market cap: โ‚ฌ17.29 Million

As of December 2025 TherapeuticsMD has a market cap of โ‚ฌ17.29 Million. This makes TherapeuticsMD the world's 10160th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of TherapeuticsMD from 2003 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ17.29 M43.2%
2024โ‚ฌ12.07 M-43.88%
2023โ‚ฌ21.52 M-56.37%
2022โ‚ฌ49.33 M-63.01%
2021โ‚ฌ0.13 B-54.77%
2020โ‚ฌ0.29 B-49.66%
2019โ‚ฌ0.58 B-26.85%
2018โ‚ฌ0.80 B-26.49%
2017โ‚ฌ1.08 B1.03%
2016โ‚ฌ1.07 B-36.1%
2015โ‚ฌ1.68 B195.46%
2014โ‚ฌ0.57 B4.43%
2013โ‚ฌ0.54 B133.88%
2012โ‚ฌ0.23 B149.32%
2011โ‚ฌ93.79 M24180.19%
2010โ‚ฌ0.38 M-97.3%
2009โ‚ฌ14.32 M1211.63%
2008โ‚ฌ1.09 M205.57%
2007โ‚ฌ0.35 M-57.21%
2006โ‚ฌ0.83 M19.7%
2005โ‚ฌ0.69 M67.67%
2004โ‚ฌ0.41 M-15.96%
2003โ‚ฌ0.49 M

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of TherapeuticsMD was reported to be:

โ‚ฌ17.29 Million
by Nasdaq info icon info icon
โ‚ฌ17.29 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Agile Therapeutics
AGRX
โ‚ฌ8.95 M-48.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
โ‚ฌ6.33 M-63.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ127.11 B 734,773.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ343.19 B 1,983,923.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚ฌ19.90 B 114,945.74%๐Ÿ‡ฌ๐Ÿ‡ง UK